Page 21234..1020..»

Analysis of Impella that was presented by Amin at AHA is flawed: Abiomed Cardiology2.0 – Cardiology2.0

Posted: November 20, 2019 at 11:48 am

A new study, Comparative Effectiveness and Costs of Impella vs. Intra-Aortic Balloon Pump in the United States, was presented by Amit Amin, MD, Washington University School of Medicine, at AHA 2019 on Sunday morning late-breaking session. The study illustrated apparent risks associated with different types of devices used in percutaneous coronary intervention(PCI). Continue reading

Posted in Clinical Cardiology | Comments Off on Analysis of Impella that was presented by Amin at AHA is flawed: Abiomed Cardiology2.0 – Cardiology2.0

NIH Awards Cleveland Clinic $12 Million to Study Link Between Gut Microbes, Heart Disease – Health Essentials from Cleveland Clinic

Posted: at 11:48 am

Stanley Hazen, M.D., Ph.D. The National Institutes of Health has awarded more than $12 million to Cleveland Clinic researchers to study the critical link between gut microbial pathways and the development of cardiometabolic diseases. The team is led by Stanley Hazen, M.D., Ph.D, director of Cleveland Clinics Center for Microbiome & Human Health Continue reading

Posted in Clinical Cardiology | Comments Off on NIH Awards Cleveland Clinic $12 Million to Study Link Between Gut Microbes, Heart Disease – Health Essentials from Cleveland Clinic

Patients With NSTE-ACS Who Underwent PCI Showed BRILINTA Monotherapy Reduced the Risk of Bleeding: TWILIGHT trial Cardiology2.0 – Cardiology2.0

Posted: at 11:48 am

New results from a pre-specified subgroup analysis of the TWILIGHT trial showed that BRILINTA (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding compared to dual antiplatelet therapy (DAPT) over 12 months in high-risk patients with non-ST elevation acute coronary syndromes (NSTE-ACS). The pre-specified subgroup analysis included 5,739 patients (64% of the overall TWILIGHT trial cohort of 9,006 patients) who had undergone successful percutaneous coronary intervention (PCI) with at least one drug eluting stent (DES) for NSTE-ACS Continue reading

Posted in Clinical Cardiology | Comments Off on Patients With NSTE-ACS Who Underwent PCI Showed BRILINTA Monotherapy Reduced the Risk of Bleeding: TWILIGHT trial Cardiology2.0 – Cardiology2.0

Recalls of Blood Pressure Med Took Toll on Patients’ Health – HealthDay

Posted: at 11:48 am

WEDNESDAY, Nov. 20, 2019 (HealthDay News) -- Emergency room visits for high blood pressure surged following last year's recall of the popular heart drug valsartan, Canadian researchers report. Within the first month of the recall, there was a 55% increase of people coming to Ontario-area emergency departments complaining of high blood pressure, said lead researcher Cynthia Jackevicius Continue reading

Posted in Clinical Cardiology | Comments Off on Recalls of Blood Pressure Med Took Toll on Patients’ Health – HealthDay

Oversupply of Congenital Heart Surgery Programs Slammed – MedPage Today

Posted: at 11:47 am

PHILADELPHIA -- The U.S. has more than double the number of congenital heart surgery centers that it needs, researchers said here. Currently, the nation boasts more than 150 such centers: 116 participating in the Society of Thoracic Surgeons (STS) National Database as of 2018, and probably another 30-40 not reporting to it, said Carl Backer, MD, of Ann & Robert H Continue reading

Posted in Cardiac Surgery | Comments Off on Oversupply of Congenital Heart Surgery Programs Slammed – MedPage Today

UTHealth expert successfully performs surgery on patient with heart problems – News-Medical.net

Posted: at 11:47 am

Cypress-Fairbanks Independent School District principal Maria Mamaux was impressed by the credentials of the surgeon recommended to repair her failing heart, but what really got her attention was the fact that he was a graduate of the same school district. "That put him at the top of my list," said Mamaux, whose open heart surgery was performed by Tom Nguyen, MD, a 1992 Cy-Fair High School graduate and the chief of cardiac surgery at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) Continue reading

Posted in Cardiac Surgery | Comments Off on UTHealth expert successfully performs surgery on patient with heart problems – News-Medical.net

Phoenix Children’s Adds Top Surgeon to its Top-Ranked Heart Center – PRNewswire

Posted: at 11:47 am

PHOENIX, Nov. 19, 2019 /PRNewswire/ --One of the country's foremost pediatric cardiothoracic surgeons has joined the top-ranked pediatric heart program at Phoenix Children's. Continue reading

Posted in Cardiac Surgery | Comments Off on Phoenix Children’s Adds Top Surgeon to its Top-Ranked Heart Center – PRNewswire

Highmark Health’s VITAL Innovation Platform is testing the benefits of Moving Analytics’ virtual cardiac rehabilitation program – P&T Community

Posted: at 11:47 am

PITTSBURGH, Nov. 20, 2019 /PRNewswire/ --Highmark Health announced today that through its VITAL Innovation Platform, it is testing Moving Analytics' MOVN virtual cardiac rehabilitation solution for delivering cardiac rehab remotely to patients with heart disease. "In support of Highmark Health's mission to create a remarkable health experience, freeing people to be their best, VITAL continues to focus on major diseases and early-stage FDA-approved health innovations that show promise for improved diagnosis, treatment and return to better health," said Anil Singh, MD, Allegheny Health Network (AHN) and VITAL medical advisor. Continue reading

Posted in Cardiac Surgery | Comments Off on Highmark Health’s VITAL Innovation Platform is testing the benefits of Moving Analytics’ virtual cardiac rehabilitation program – P&T Community

CARMAT granted authorization to resume the PIVOTAL study in the Czech Republic – Business Wire

Posted: at 11:47 am

PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the worlds most advanced total artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announced that it has received authorization to resume the PIVOTAL study in the Czech Republic. The implants will be performed at the Institute of Clinical and Experimental Medicine (IKEM) in Prague, whose teams have benefited from a major learning curve acquired through implanting the CARMAT device during the first part of the PIVOTAL study. The screening for the second patient cohort, who will receive the new prostheses produced at the Bois-dArcy site, is already underway. Continue reading

Posted in Cardiac Surgery | Comments Off on CARMAT granted authorization to resume the PIVOTAL study in the Czech Republic – Business Wire

Over 60 New Safety Reports Filed With FDA for Maquet IABPs Turning Off During Use – Diagnostic and Interventional Cardiology

Posted: at 11:47 am

November 19, 2019 Since Maquet/Datascope first recalledall of itsintra-aortic balloon pumps (IABP)due to reports of the batteries failing in November 2018, a year later theU.S. Food and Drug Administration said its has received more than 60 additional medical device reports related to this issue. These included two patient deaths and one serious patient injury Continue reading

Posted in Cardiac Surgery | Comments Off on Over 60 New Safety Reports Filed With FDA for Maquet IABPs Turning Off During Use – Diagnostic and Interventional Cardiology

Page 21234..1020..»